• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯巴比妥在儿童期的药代动力学。

Pharmacokinetics of phenobarbital in childhood.

作者信息

Heimann G, Gladtke E

出版信息

Eur J Clin Pharmacol. 1977 Dec 2;12(4):305-10. doi: 10.1007/BF00607431.

DOI:10.1007/BF00607431
PMID:590316
Abstract

In 14 neonates 1-4 weeks old, 30 babies aged 1-12 months, and 7 infants of 1-5 years of age, the serum levels of phenobarbital were determined by a gas chromatographic micro-method after intravenous injection of phenobarbital 5-10 mg per kg body weight. It was possible to calculate the pharmacokinetic parameters using a two compartment open model. The distribution volumes within the individual age groups and the rate constants k12 and k21 showed no significant differences, but the elimination half-life was significantly longer in neonates (118.6+/-16.1h) than in babies (62.9+/-5.2h) or infants (68.5+/-3.2h).

摘要

对14名1至4周龄的新生儿、30名1至12个月大的婴儿以及7名1至5岁的幼儿,静脉注射每公斤体重5至10毫克苯巴比妥后,采用气相色谱微量法测定血清苯巴比妥水平。使用二室开放模型可以计算药代动力学参数。各年龄组内的分布容积以及速率常数k12和k21无显著差异,但新生儿的消除半衰期(118.6±16.1小时)明显长于婴儿(62.9±5.2小时)或幼儿(68.5±3.2小时)。

相似文献

1
Pharmacokinetics of phenobarbital in childhood.苯巴比妥在儿童期的药代动力学。
Eur J Clin Pharmacol. 1977 Dec 2;12(4):305-10. doi: 10.1007/BF00607431.
2
[Pharmacokinetic data on phenobarbital. Study on the influence of gestational age and dysmaturity].[苯巴比妥的药代动力学数据。关于胎龄和发育不成熟影响的研究]
Arch Fr Pediatr. 1976 Nov;33(G):905-13.
3
Individualizing phenobarbital dosing in neonates.新生儿苯巴比妥剂量个体化
Clin Pharm. 1983 May-Jun;2(3):258-62.
4
Distribution of phenobarbital in serum, brain and other organs from pediatric patients.苯巴比妥在儿科患者血清、脑及其他器官中的分布。
Dev Pharmacol Ther. 1984;7(3):153-9. doi: 10.1159/000457158.
5
Phenobarbital pharmacokinetics in neonates.新生儿苯巴比妥的药代动力学
Clin Pharmacol Ther. 1978 Mar;23(3):346-50. doi: 10.1002/cpt1978233346.
6
[Pharmacokinetics of injectable phenobarbital in the premature infant. Study of a new lyophilized form].[注射用苯巴比妥在早产儿中的药代动力学。一种新型冻干剂型的研究]
Arch Fr Pediatr. 1985 Apr;42(4):317-20.
7
Population pharmacokinetic investigation of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants.利用日本新生儿和婴儿的常规临床药代动力学数据,通过混合效应模型对苯巴比妥进行群体药代动力学研究。
J Clin Pharm Ther. 2005 Apr;30(2):159-63. doi: 10.1111/j.1365-2710.2005.00619.x.
8
Studies with stable isotopes II: Phenobarbital pharmacokinetics during monotherapy.稳定同位素研究II:单一疗法期间苯巴比妥的药代动力学
J Clin Pharmacol. 1985 Jan-Feb;25(1):51-8. doi: 10.1002/j.1552-4604.1985.tb02800.x.
9
Pharmacokinetics of carbamazepine in the neonate and in the child.
Int J Clin Pharmacol Biopharm. 1979 Feb;17(2):90-6.
10
Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients.苯巴比妥与苯妥英在动物及癫痫患者体内的相互作用。
Ann N Y Acad Sci. 1971 Jul 6;179:88-107. doi: 10.1111/j.1749-6632.1971.tb46892.x.

引用本文的文献

1
Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling.预测新生儿的分布容积:基于生理学的药代动力学建模的性能
Pharmaceutics. 2023 Sep 19;15(9):2348. doi: 10.3390/pharmaceutics15092348.
2
Pharmacokinetic variability of phenobarbital: a systematic review of population pharmacokinetic analysis.苯巴比妥的药代动力学变异性:系统评价群体药代动力学分析。
Eur J Clin Pharmacol. 2021 Mar;77(3):291-309. doi: 10.1007/s00228-020-03011-x. Epub 2020 Oct 19.
3
Effect of Intravenous Phenobarbital on Left Ventricular Myocardial Contractility Determined by Echocardiography in Children.

本文引用的文献

1
[Cumulation and elimination of phenobarbital].[苯巴比妥的蓄积与消除]
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1962;243:479-94.
2
Plasma levels and urinary excretion of three barbituric acids after oral administration to man.
Acta Pharmacol Toxicol (Copenh). 1954;10(2):147-65. doi: 10.1111/j.1600-0773.1954.tb01332.x.
3
[CLINICAL AND EXPERIMENTAL STUDIES ON DRUG DOSAGE IN CHILDHOOD. 2. BARBITURATE DERIVATIVES].[儿童用药剂量的临床与实验研究。2. 巴比妥类衍生物]
静脉注射苯巴比妥对儿童超声心动图测定的左心室心肌收缩力的影响
Kans J Med. 2019 May 15;12(2):40-44. eCollection 2019 May.
4
Population pharmacokinetics of phenobarbital in infants with neonatal encephalopathy treated with therapeutic hypothermia.新生儿脑病亚低温治疗患儿苯巴比妥的群体药代动力学研究。
Pediatr Crit Care Med. 2013 Feb;14(2):194-202. doi: 10.1097/PCC.0b013e31825bbbc2.
5
Pharmacokinetics and clinical effect of phenobarbital in children with severe falciparum malaria and convulsions.苯巴比妥在患有严重恶性疟和惊厥的儿童中的药代动力学及临床效果。
Br J Clin Pharmacol. 2003 Oct;56(4):453-7. doi: 10.1046/j.1365-2125.2003.01951.x.
6
Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.抗癫痫药物治疗的优化。血清药物浓度监测的重要性。
Clin Pharmacokinet. 1996 Aug;31(2):120-30. doi: 10.2165/00003088-199631020-00004.
7
Determination of phenobarbitone population clearance values for South African children.南非儿童苯巴比妥群体清除率值的测定。
Eur J Clin Pharmacol. 1995;48(5):381-3. doi: 10.1007/BF00194954.
8
Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide.抗癫痫药物在儿科患者中的临床药代动力学。第一部分:苯巴比妥、扑米酮、丙戊酸、乙琥胺和甲琥胺。
Clin Pharmacokinet. 1995 Oct;29(4):257-86. doi: 10.2165/00003088-199529040-00005.
9
Enteral absorption and bioavailability in children in relation to age.
Eur J Clin Pharmacol. 1980 Jul;18(1):43-50. doi: 10.1007/BF00561477.
10
Placental transfer and pharmacokinetics of primidone and its metabolites phenobarbital, PEMA and hydroxyphenobarbital in neonates and infants of epileptic mothers.
Eur J Clin Pharmacol. 1980 Jul;18(1):31-42. doi: 10.1007/BF00561476.
Arch Kinderheilkd. 1964 Jun;170:213-21.
4
ACCUMULATION OF PHENOBARBITAL IN MAN.
Epilepsia. 1963 Dec;4:199-206. doi: 10.1111/j.1528-1157.1963.tb05221.x.
5
[Intravital & postmortem reduction of barbitals].[巴比妥类药物的活体及死后还原]
Arch Toxikol. 1958;17(2):93-150.
6
Changes in body water compartments during growth.生长过程中身体水分 compartments 的变化。 (注:这里“compartments”可能是“compartments”拼写错误,推测可能是“compartments”,意为“部分、分区” ,结合语境可译为“身体水分分布区域” ,但按要求未作修改。)
Acta Paediatr Suppl (Upps). 1957 Jan;46(suppl 110):1-68.
7
Metabolic oxidation of phenobarbital to p-hydroxyphenobarbital.苯巴比妥代谢氧化为对羟基苯巴比妥。
Science. 1954 Sep 24;120(3117):494. doi: 10.1126/science.120.3117.494.
8
Phenobarbital: studies of elimination, accumulation, tolerance, and dosage schedules.苯巴比妥:消除、蓄积、耐受性及给药方案的研究
J Pharmacol Exp Ther. 1954 Aug;111(4):425-35.
9
Placental transfer of phenobarbitone in epileptic women, and elimination in newborns.
Lancet. 1967 Oct 21;2(7521):860-1. doi: 10.1016/s0140-6736(67)92593-7.
10
Estimation of volume of distribution and half-life of a compound after rapid intravenous injection.快速静脉注射后化合物的分布容积和半衰期的估算。
J Pharm Sci. 1967 Apr;56(4):529-31. doi: 10.1002/jps.2600560424.